Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C5orf34 antisense RNA 1 (C5orf34-AS1) is a long non-coding RNA (lncRNA) transcribed from chromosome 5 (5p12, 43,483,545-43,545,445) on the forward DNA strand. As an antisense RNA, C5orf34-AS1 is believed to participate in gene expression regulation by targeting promoter regions, thereby negatively regulating expression of overlapping or adjacent genes, likely through transcriptional interference or chromatin-based mechanisms. While general roles for antisense lncRNAs include regulation of alternative splicing, epigenetic modification, and acting as competing endogenous RNAs, there is currently no evidence implicating C5orf34-AS1 as a therapeutic target or with established drug interactions, disease association, or biomarker function. The specific physiological or pathological function of C5orf34-AS1 remains insufficiently characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C5orf34 antisense RNA 1 (C5orf34-AS1).